Key Financial Inc’s Dr. Reddy's Laboratories RDY Stock Holding History

Key Financial Inc’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3K	Hold	710	–	–	﹤0.01%	863
2026 Q1	$9.83K	Hold	710	–	–	﹤0.01%	885
2025 Q4	$9.97K	Hold	710	–	–	﹤0.01%	886
2025 Q3	$10.1K	Hold	710	–	–	﹤0.01%	878
2025 Q2	$10.7K	Hold	710	–	–	﹤0.01%	838
2025 Q1	$9.37K	Hold	710	–	–	﹤0.01%	832
2024 Q4	$11.2K	Hold	710	–	–	﹤0.01%	797
2024 Q3	$11.3K	Hold	710	–	–	﹤0.01%	763
2024 Q2	$10.8K	Hold	710	–	–	﹤0.01%	752
2024 Q1	$10.4K	Hold	710	–	–	﹤0.01%	741
2023 Q4	$9.88K	Hold	710	–	–	﹤0.01%	739
2023 Q3	$9.5K	Hold	710	–	–	﹤0.01%	725
2023 Q2	$8.96K	Buy	+710	New	+$8.29K	﹤0.01%	764

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Key Financial Inc's RDY Position: Q2 2026 in Review

Key Financial Inc held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 710 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #863.

Key Financial Inc first reported a position in RDY in Q2 2023 and has held it in 13 quarters since. The position peaked at $11.3K in Q3 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Key Financial Inc held 710 shares of Dr. Reddy's Laboratories worth $10.3K as of Q2 2026.
Key Financial Inc left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #863 holding.
Key Financial Inc first reported a position in Dr. Reddy's Laboratories in Q2 2023 and has held it in 13 quarters since.
Key Financial Inc's Dr. Reddy's Laboratories position peaked at $11.3K in Q3 2024.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.